KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Total Liabilities (2016 - 2025)

Zoetis (ZTS) has disclosed Total Liabilities for 13 consecutive years, with $9.8 billion as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 6.99% to $9.8 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $9.8 billion, a 6.99% increase, with the full-year FY2024 number at $9.5 billion, up 1.85% from a year prior.
  • Total Liabilities was $9.8 billion for Q3 2025 at Zoetis, up from $9.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $10.5 billion in Q4 2022 to a low of $9.0 billion in Q3 2022.
  • A 5-year average of $9.4 billion and a median of $9.3 billion in 2023 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: grew 12.46% in 2022, then dropped 11.66% in 2023.
  • Zoetis' Total Liabilities stood at $9.4 billion in 2021, then rose by 12.46% to $10.5 billion in 2022, then dropped by 11.66% to $9.3 billion in 2023, then increased by 1.85% to $9.5 billion in 2024, then rose by 3.11% to $9.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Total Liabilities are $9.8 billion (Q3 2025), $9.5 billion (Q2 2025), and $9.4 billion (Q1 2025).